Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Leisheng [1 ,2 ]
Li, Jing [3 ]
Guo, Liang [4 ]
机构：
[1] Shandong First Med Univ, Teaching Hosp, Peoples Hosp Jinan 4, Sci & Technol Innovat Ctr, 50 Shifan Rd, Jinan, Shandong, Peoples R China
[2] Gansu Prov Hosp, Natl Hlth Commiss Key Lab Diag & Therapy Gastroint, Lanzhou, Peoples R China
[3] Shandong First Med Univ, Peoples Hosp Jinan City 4, Teaching Hosp, Dept Oncol, Jinan, Peoples R China
[4] Shandong First Med Univ, Peoples Hosp Jinan City 4, Teaching Hosp, Radiotherapy Dept Oncol, Jinan, Peoples R China
来源：
JAMA ONCOLOGY | 2024年
关键词：
D O I：
10.1001/jamaoncol.2024.4211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer-Reply
    Sorin, Mark
    Prosty, Connor
    Spicer, Jonathan D.
    [J]. JAMA ONCOLOGY, 2024,
  • [2] Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Jiang, Juan
    Wang, Yuling
    Gao, Yang
    Sugimura, Haruhiko
    Minervini, Fabrizio
    Uchino, Junji
    Halmos, Balazs
    Yendamuri, Sai
    Velotta, Jeffrey B.
    Li, Min
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 277 - +
  • [3] A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer
    Wei Liu
    Tiantian Zhang
    Qian Zhang
    Li Li
    Chunhua Xu
    [J]. BMC Pulmonary Medicine, 22
  • [4] A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer
    Liu, Wei
    Zhang, Tiantian
    Zhang, Qian
    Li, Li
    Xu, Chunhua
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [5] Neoadjuvant immunotherapy versus chemoimmunotherapy in non-small cell lung cancer: A protocol for systematic review and meta-analysis
    Zhu, Qunying
    Chen, Guini
    Liu, Yunzhong
    Zhou, Yu
    [J]. MEDICINE, 2023, 102 (09) : E33166
  • [6] Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis
    Federico, Alessandro Di
    Giglio, Andrea De
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01) : 29 - 42
  • [7] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [8] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    [J]. Current Treatment Options in Oncology, 2021, 22
  • [9] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [10] Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
    Cao, Christopher
    Le, Anthony
    Bott, Matthew
    Yang, Chi-Fu Jeffrey
    Gossot, Dominique
    Melfi, Franca
    Tian, David H.
    Guo, Allen
    [J]. CURRENT ONCOLOGY, 2021, 28 (06) : 4686 - 4701
12345